Dopamine Agents - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.

7 Sep 2009 CONTEXT: Kidney graft function after transplantation can be improved through pharmacological donor pretreatment to limit organ injury from cold preservation. OBJECTIVE: To determine whether pretreatment of brain-dead donors with low-dose dopamine ... Read more...

Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions.

30 Jul 2009 INTRODUCTION: Tinnitus is a frequent disorder and very difficult to treat. Both animal studies and clinical observations suggest that dopaminergic substances might have potential for the treatment of tinnitus. Here, we investigated the dopamine ... Read more...

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.

22 Jul 2009 BACKGROUND: Alzheimer's disease (AD) is the commonest cause of dementia. Cholinesterase inhibitors, such as donepezil, are the drug class with the best evidence of efficacy, licensed for mild to moderate AD, while the glutamate antagonist memantine ... Read more...

Latest indexed articles for 'Dopamine Agents - Therapeutic use'

These are the very latest articles for this heading:

• Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. 7 Sep 2009
• Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions. 30 Jul 2009
• DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. 22 Jul 2009
• Reduced ventrolateral fMRI response during observation of emotional gestures related to the degree of dopaminergic impairment in Parkinson disease. 29 Jun 2009
• Effects of amantadine in children with impaired consciousness caused by acquired brain injury: a pilot study. 29 Jun 2009
• Parkinson's disease. 11 Jun 2009
• Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. 8 Jun 2009
• Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. 31 May 2009
• Donepezil in severe Alzheimer's disease. 30 May 2009
• Successful management of pregnancy in a patient with Segawa disease: case report and literature review. 30 May 2009
• Analysis of interactive effect of stretch reflex and shortening reaction on rigidity in Parkinson's disease. 29 May 2009
• Too soon for dopaminergics in the management of restless legs syndrome in children. 25 May 2009
• Movement disorders in children: recent advances in management. 22 May 2009
• [Socioeconomic relevance of the idiopathic restless legs syndrome (RLS) in Germany: cost-of-illness study] 14 May 2009
• Paraphilia and other disturbed behavior associated with dopamimetic treatment for Parkinson's disease. 13 May 2009
• Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa response. 13 May 2009
• Treatment of Alzheimer's disease in the long-term-care setting. 13 May 2009
• On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter? 10 May 2009
• Restless legs syndrome. 29 Apr 2009
• Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. 29 Apr 2009

See a longer list of these articles.

Technical information about 'Dopamine Agents'

Definition: Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

Registry Number: 0

Descriptor UI: D015259

Alternative terms: Dopamine Agents; Agents, Dopamine; Dopaminergic Drugs; Drugs, Dopaminergic; Dopamine Drugs; Drugs, Dopamine; Dopaminergic Agents; Agents, Dopaminergic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.150; D27.505.696.577.150;

Online Note: use DOPAMINE AGENTS to search DOPAMINERGIC AGENTS 1989-94

History Note: 95; was DOPAMINERGIC AGENTS 1989-94; DOPAMINE NEURON AGENTS (NON MESH) was heading 1995

Technical Notes: GEN or unspecified; prefer specific groups or specific drugs